Background: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.
Objective: To provide evidence-based consensus recommendations for patients with HS in seven special patient populations: i) pregnancy, ii) breastfeeding, iii) pediatrics, iv) malignancy, v) tuberculosis infection, vi) hepatitis B or C infection, and vii) HIV disease.
Methods: Recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.
Results: 119 expert consensus statements are provided for the management of patients with HS across these seven special patient populations.
Keywords: Antiandrogens; HIV; North America; antibiotics; biologics; breastfeeding; comorbidity; guidelines; hepatitis B; hepatitis C; hidradenitis suppurativa; immunomodulators; immunosuppressive; malignancy; management; pediatric; pregnancy; safety; therapy; tuberculosis.
Copyright © 2024. Published by Elsevier Inc.